Blood Cancer Journal (Mar 2021)
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis
- Rashmi Kanagal-Shamanna,
- Guillermo Montalban-Bravo,
- Panagiotis Katsonis,
- Koji Sasaki,
- Caleb A. Class,
- Elias Jabbour,
- David Sallman,
- Anthony Michael Hunter,
- Christopher Benton,
- Kelly S. Chien,
- Rajyalakshmi Luthra,
- Carlos E. Bueso-Ramos,
- Tapan Kadia,
- Michael Andreeff,
- Rami S. Komrokji,
- Najla H Al Ali,
- Nicholas Short,
- Naval Daver,
- Mark J. Routbort,
- Joseph D. Khoury,
- Keyur Patel,
- Irene Ganan-Gomez,
- Yue Wei,
- Gautam Borthakur,
- Farhad Ravandi,
- Kim-Anh Do,
- Kelly A. Soltysiak,
- Olivier Lichtarge,
- L. Jeffrey Medeiros,
- Hagop Kantarjian,
- Guillermo Garcia-Manero
Affiliations
- Rashmi Kanagal-Shamanna
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Guillermo Montalban-Bravo
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Panagiotis Katsonis
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Koji Sasaki
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Caleb A. Class
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center
- Elias Jabbour
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- David Sallman
- Malignant Hematology Department, H. Lee Moffitt Cancer Center
- Anthony Michael Hunter
- Malignant Hematology Department, H. Lee Moffitt Cancer Center
- Christopher Benton
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Kelly S. Chien
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Rajyalakshmi Luthra
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Carlos E. Bueso-Ramos
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Tapan Kadia
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Michael Andreeff
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Rami S. Komrokji
- Malignant Hematology Department, H. Lee Moffitt Cancer Center
- Najla H Al Ali
- Malignant Hematology Department, H. Lee Moffitt Cancer Center
- Nicholas Short
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Naval Daver
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Mark J. Routbort
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Joseph D. Khoury
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Keyur Patel
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Irene Ganan-Gomez
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Yue Wei
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Gautam Borthakur
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Farhad Ravandi
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Kim-Anh Do
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Kelly A. Soltysiak
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Olivier Lichtarge
- Department of Molecular and Human Genetics, Baylor College of Medicine
- L. Jeffrey Medeiros
- Department of Hematopathology and Molecular Diagnostics, Division of Pathology and Lab Medicine, The University of Texas MD Anderson Cancer Center
- Hagop Kantarjian
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Guillermo Garcia-Manero
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1038/s41408-021-00446-y
- Journal volume & issue
-
Vol. 11,
no. 3
pp. 1 – 5
Abstract
No abstracts available.
